Editorial: Lectins from plants, algae, fungi, bacteria and animal therapeutic tools for SARS-CoV-2 and other pathogenic enveloped viruses, in a “one-health” perspective

• Els J. M. Van Damme,
• Pierre Rougé

Affiliations

Els J. M. Van Damme

Biotechnology, Ghent University, Ghent, Belgium

Pierre Rougé

Pharmadev, Université Toulouse III Paul Sabatier, Toulouse, France